Teva is the latest drugmaker to file suit against Medicare negotiations. But unlike other companies that have challenged the ...

HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its ...

After seeing its Covid-19 drug fail in a Phase 3 trial last year, Shionogi on Thursday won a $375 million award from HHS to ...

The EMA's human medicines committee recommended 114 medicines for approval in 2024, marking the highest number of positive ...

Novartis won a potentially short-lived victory in its fight across multiple courts to keep generic versions of its ...

UnitedHealth CEO Witty addresses healthcare issues post Brian Thompson's killing, emphasizes existing solutions and defends ...

Most clinical trials for Huntington’s disease have run aground in the last few years, but academic researchers haven’t been ...

Novartis is the latest drugmaker to sue the government for allegedly rejecting its proposed model to distribute federal drug ...

Studies show telemedicine increased therapy access 30% during pandemic, but mainly benefited wealthy, white, urban patients ...

US regulators have rejected a T cell therapy for a rare and serious transplant complication related to Epstein-Barr virus ...

It’s time for one last look at the biotech numbers for 2024. And you might be surprised by some bullish charts below — ...

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, ...